Yunnan Walvax Buys 58% Stake in Vaccine-Maker Zerun Biotech

by Richard Daverman, PhD

January 14, 2013 -- Yunnan Walvax Biotech paid $49.2 million to acquire a 58% stake in Shanghai Zerun Biotech, a fellow vaccine company. Walvax bought the stake by buying Wison (China) Investment’s equity in Zerun for $20.8 million, and then investing another $28.4 in Zerun directly. For Walvax, the deal improves its R&D capability in recombinant vaccines, and it adds to the pipeline one marketed vaccine along with seven others in various stages of development. More details....

Stock Symbol: (SHE: 300142)